Cytarabine autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells Bone Marrow Cells Neural Stem Cells T-Lymphocytes Induced Pluripotent Stem Cells Cells, Cultured Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Spermatogonia Neoplastic Stem Cells Plant Stems Allografts

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases55

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Leukemia, Myeloid, Acute Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Myelodysplastic Syndromes Leukemia, Myeloid Enteropathy-Associated T-Cell Lymphoma Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Acute Disease Leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm Recurrence, Local Neutropenia Lymphoma, AIDS-Related Disease Progression Hepatic Veno-Occlusive Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Neuroblastoma Neoplasms Hematologic Diseases Stomatitis Cytomegalovirus Infections Anemia, Aplastic Central Nervous System Neoplasms Breast Neoplasms Mucositis Infection Severe Combined Immunodeficiency Chromosome Aberrations Medulloblastoma Lymphoproliferative Disorders Thrombocytopenia Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Disease Models, Animal Leukemia, Myeloid, Accelerated Phase Leukemic Infiltration Postoperative Complications Leukemia, Myelomonocytic, Acute Blood Group Incompatibility Paraproteinemias Anemia, Refractory, with Excess of Blasts Translocation, Genetic

Chemicals and Drugs56

Cytarabine Melphalan Etoposide Myeloablative Agonists Cyclophosphamide Carmustine Vincristine Thiotepa Dexamethasone Busulfan Boronic Acids Pyrazines Antibodies, Monoclonal, Murine-Derived Doxorubicin Idarubicin Antigens, CD34 Thalidomide Antineoplastic Agents, Alkylating Prednisone Podophyllotoxin Ifosfamide Granulocyte Colony-Stimulating Factor Mitoxantrone Antineoplastic Agents Immunosuppressive Agents Antibodies, Monoclonal Keratins, Type II Vidarabine Carboplatin Immunoglobulin Light Chains Daunorubicin Cisplatin HLA Antigens Methotrexate Antilymphocyte Serum Bleomycin Immunoconjugates Stem Cell Factor Arabinonucleosides Recombinant Proteins Cyclosporine Antimetabolites, Antineoplastic Minor Histocompatibility Antigens Prednisolone Antigens, CD Benzamides Pyrimidines Tacrolimus Antigens, CD20 Immunologic Factors Nitrogen Mustard Compounds Biological Markers Myeloma Proteins Antibodies, Neoplasm Piperazines Methylprednisolone

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Salvage Therapy Disease-Free Survival Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Survival Rate Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Blood Component Removal Prospective Studies Histocompatibility Testing Drug Administration Schedule Feasibility Studies Life Tables Fatal Outcome Radioimmunotherapy Heart Transplantation Risk Factors Lung Transplantation Immunotherapy Blood Transfusion, Autologous Organ Transplantation Transplantation, Isogeneic Kaplan-Meier Estimate Lymphocyte Transfusion Clinical Trials as Topic Flow Cytometry Consolidation Chemotherapy Treatment Failure Transplantation Pilot Projects Islets of Langerhans Transplantation Immunosuppression Neoplasm Staging Lymphocyte Depletion Positron-Emission Tomography Cell Separation Pancreas Transplantation Immunophenotyping Platelet Count Predictive Value of Tests Transplantation, Heterologous Donor Selection Cell Culture Techniques Immunomagnetic Separation Severity of Illness Index Randomized Controlled Trials as Topic Stem Cell Research Leukocyte Count Proportional Hazards Models Multivariate Analysis Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Cohort Studies Actuarial Analysis Disease Models, Animal Infusions, Intravenous Transplantation, Heterotopic Colony-Forming Units Assay Platelet Transfusion Heart-Lung Transplantation Immunotherapy, Adoptive Reverse Transcriptase Polymerase Chain Reaction Radiotherapy Lymphocyte Count Incidence Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes25

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Stem Cell Niche Dose-Response Relationship, Drug Graft Rejection Graft vs Tumor Effect Chimerism Cell Lineage Cell Proliferation Platelet Count Regeneration Chromosome Aberrations Transplantation Tolerance Immunocompromised Host Leukocyte Count Virus Activation Drug Resistance, Neoplasm Cell Survival Lymphocyte Count Translocation, Genetic

Disciplines and Occupations1

Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Life Tables Fatal Outcome Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Life Tables Fatal Outcome Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Age Factors Predictive Value of Tests Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Proportional Hazards Models Multivariate Analysis Cohort Studies Actuarial Analysis Tissue and Organ Procurement Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Cytarabine Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Stem Cells Salvage Therapy Etoposide Disease-Free Survival Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Myeloablative Agonists Cyclophosphamide Carmustine Vincristine Bone Marrow Transplantation Graft vs Host Disease Hematopoietic Stem Cell Mobilization Survival Rate Bone Marrow Purging Thiotepa Hematologic Neoplasms Lymphoma, Mantle-Cell Survival Analysis Whole-Body Irradiation Retrospective Studies Amyloidosis Dexamethasone Busulfan Hematopoietic Stem Cells Boronic Acids Pyrazines Graft Survival Antibodies, Monoclonal, Murine-Derived Prognosis Doxorubicin Leukemia, Myeloid, Acute Idarubicin Lymphoma, Follicular Autografts Antigens, CD34 Follow-Up Studies Lymphoma, T-Cell, Peripheral Liver Transplantation Thalidomide Antineoplastic Agents, Alkylating Induction Chemotherapy Prednisone Mesenchymal Stem Cell Transplantation Podophyllotoxin Ifosfamide Granulocyte Colony-Stimulating Factor Mitoxantrone Leukapheresis Lymphoma Time Factors Transplantation Chimera Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Tissue Donors Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Antineoplastic Agents Myelodysplastic Syndromes Cell Transplantation Kidney Transplantation Leukemia, Myeloid Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Lymphoma, B-Cell Infusions, Spinal Leukemia, Plasma Cell Adult Stem Cells Neoplasms, Second Primary Blood Component Removal Immunosuppressive Agents Prospective Studies Histocompatibility Testing Drug Administration Schedule Acute Disease Antibodies, Monoclonal Feasibility Studies Keratins, Type II Leukemia Cell Differentiation Vidarabine Life Tables Histocompatibility Precursor Cell Lymphoblastic Leukemia-Lymphoma Fatal Outcome Mesenchymal Stromal Cells

No FAQ available that match "cytarabine autologous stem cell transplantation"